These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34241661)

  • 1. Quantitative dynamic contrast-enhanced MRI and readout segmentation of long variable echo-trains diffusion-weighted imaging in differentiating parotid gland tumors.
    Huang N; Xiao Z; Chen Y; She D; Guo W; Yang X; Chen Q; Cao D; Chen T
    Neuroradiology; 2021 Oct; 63(10):1709-1719. PubMed ID: 34241661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion kurtosis imaging and dynamic contrast-enhanced MRI for the differentiation of parotid gland tumors.
    Huang N; Chen Y; She D; Xing Z; Chen T; Cao D
    Eur Radiol; 2022 Apr; 32(4):2748-2759. PubMed ID: 34642805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of diffusion kurtosis imaging and dynamic contrast-enhanced magnetic resonance imaging in the differential diagnosis of parotid gland tumors.
    Liu Z; Wen B; Zhang Z; Qu F; Wu Y; Grimm R; Zhang Y; Cheng J; Zhang Y
    Gland Surg; 2024 Jul; 13(7):1254-1268. PubMed ID: 39175702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of parotid gland tumors: added value of permeability MR imaging to DWI and DCE-MRI.
    Yabuuchi H; Kamitani T; Sagiyama K; Yamasaki Y; Hida T; Matsuura Y; Hino T; Murayama Y; Yasumatsu R; Yamamoto H
    Eur Radiol; 2020 Dec; 30(12):6402-6412. PubMed ID: 32613285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of pre-/post-contrast-enhanced T1 mapping and readout segmentation of long variable echo-train diffusion-weighted imaging in differentiating parotid gland tumors.
    Wen B; Zhang Z; Fu K; Zhu J; Liu L; Gao E; Qi J; Zhang Y; Cheng J; Qu F; Zhu J
    Eur J Radiol; 2023 May; 162():110748. PubMed ID: 36905715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential diagnosis of parotid gland tumours: Application of SWI combined with DWI and DCE-MRI.
    Xu Z; Chen M; Zheng S; Chen S; Xiao J; Hu Z; Lu L; Yang Z; Lin D
    Eur J Radiol; 2022 Jan; 146():110094. PubMed ID: 34906852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional, diffusion, and dynamic contrast-enhanced MRI findings for differentiating metaplastic Warthin's tumor of the parotid gland.
    Jia CH; Wang SY; Li Q; Qiu JM; Kuai XP
    Sci Prog; 2021; 104(2):368504211018583. PubMed ID: 34003684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic efficacy of diffusion-weighted imaging and semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging in salivary gland tumors.
    Gökçe E; Beyhan M
    World J Radiol; 2023 Jan; 15(1):20-31. PubMed ID: 36721673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
    Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
    Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multiparametric analysis based on DCE-MRI to improve the accuracy of parotid tumor discrimination.
    Xu Z; Zheng S; Pan A; Cheng X; Gao M
    Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2228-2234. PubMed ID: 31372671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
    Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
    World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T2 mapping and readout segmentation of long variable echo-train diffusion-weighted imaging for the differentiation of parotid gland tumors.
    Baohong W; Jing Z; Zanxia Z; Kun F; Liang L; Eryuan G; Yong Z; Fei H; Jingliang C; Jinxia Z
    Eur J Radiol; 2022 Jun; 151():110265. PubMed ID: 35472650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
    Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
    J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of quantitative multiparametric MRI in differentiating pleomorphic adenomas from malignant epithelial tumors in lacrimal gland.
    Wang Y; Song L; Guo J; Xian J
    Neuroradiology; 2020 Sep; 62(9):1141-1147. PubMed ID: 32430642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating parotid tumors by quantitative signal intensity evaluation on MR imaging.
    Matsusue E; Fujihara Y; Matsuda E; Tokuyasu Y; Nakamoto S; Nakamura K; Ogawa T
    Clin Imaging; 2017; 46():37-43. PubMed ID: 28704680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histogram analysis of apparent diffusion coefficient maps for differentiating malignant from benign parotid gland tumors.
    Ma G; Zhu LN; Su GY; Hu H; Qian W; Bu SS; Xu XQ; Wu FY
    Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2151-2157. PubMed ID: 29961924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravoxel Incoherent Motion Magnetic Resonance Imaging for Assessing Parotid Gland Tumors: Correlation and Comparison with Arterial Spin Labeling Imaging.
    Ma G; Xu XQ; Zhu LN; Jiang JS; Su GY; Hu H; Bu SS; Wu FY
    Korean J Radiol; 2021 Feb; 22(2):243-252. PubMed ID: 32932565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor blood flow and apparent diffusion coefficient histogram analysis for differentiating malignant salivary tumors from pleomorphic adenomas and Warthin's tumors.
    Tanaka F; Umino M; Maeda M; Nakayama R; Inoue K; Kogue R; Obara M; Sakuma H
    Sci Rep; 2022 Apr; 12(1):5947. PubMed ID: 35396374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging quality of PROPELLER diffusion-weighted MR imaging and its diagnostic performance in distinguishing pleomorphic adenomas from Warthin tumors of the parotid gland.
    Liu YJ; Lee YH; Chang HC; Chung HW; Wang CW; Juan CH; Chu YH; Lee JC; Juan CJ
    NMR Biomed; 2020 May; 33(5):e4282. PubMed ID: 32124504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.